世界の吸入＆点鼻薬ジェネリック医薬品市場予測（～2028年）：コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他

• 英文タイトル：Global Inhalation and Nasal Spray Generic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8856 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

吸入＆点鼻薬ジェネリック医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の吸入＆点鼻薬ジェネリック医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 吸入＆点鼻薬ジェネリック医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他 用途別セグメントは次のように区分されます。 ・喘息、COPD、アレルギー性鼻炎、その他 世界の吸入＆点鼻薬ジェネリック医薬品市場の主要な市場プレーヤーは以下のとおりです。 ・Teva、Sandoz (Novartis)、Mylan、Allergan、Cipla、Akorn、Apotex、Sun Pharma (Ranbaxy)、Nephron Pharma、Beximco Pharma、Hikma (Roxane)、XIANJU PHARMA 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、吸入＆点鼻薬ジェネリック医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な吸入＆点鼻薬ジェネリック医薬品メーカーの企業概要、2019年～2022年までの吸入＆点鼻薬ジェネリック医薬品の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な吸入＆点鼻薬ジェネリック医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別吸入＆点鼻薬ジェネリック医薬品の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの吸入＆点鼻薬ジェネリック医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での吸入＆点鼻薬ジェネリック医薬品市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および吸入＆点鼻薬ジェネリック医薬品の産業チェーンを掲載しています。 ・第13、14、15章では、吸入＆点鼻薬ジェネリック医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Teva、Sandoz (Novartis)、Mylan、Allergan、Cipla、Akorn、Apotex、Sun Pharma (Ranbaxy)、Nephron Pharma、Beximco Pharma、Hikma (Roxane)、XIANJU PHARMA ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：コルチコステロイド、気管支拡張薬、組み合わせ、充血除去薬スプレー、その他 ・用途別分析2017年-2028年：喘息、COPD、アレルギー性鼻炎、その他 ・吸入＆点鼻薬ジェネリック医薬品の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・吸入＆点鼻薬ジェネリック医薬品のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・吸入＆点鼻薬ジェネリック医薬品のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・吸入＆点鼻薬ジェネリック医薬品の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・吸入＆点鼻薬ジェネリック医薬品の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Inhalation and Nasal Spray Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Inhalation and Nasal Spray Generic Drugs market size is estimated to be worth US$ 9067.6 million in 2021 and is forecast to a readjusted size of USD 13660 million by 2028 with a CAGR of 6.0% during review period. Asthma accounting for % of the Inhalation and Nasal Spray Generic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Corticosteroids segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Inhalation and Nasal Spray Generic Drugs include Teva, Sandoz (Novartis), Mylan, Allergan, and Cipla, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Inhalation and Nasal Spray Generic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Corticosteroids
Bronchodilators
Combinations
Decongestant Sprays
Others
Market segment by Application can be divided into
Asthma
COPD
Allergic Rhinitis
Others
The key market players for global Inhalation and Nasal Spray Generic Drugs market are listed below:
Teva
Sandoz (Novartis)
Mylan
Allergan
Cipla
Akorn
Apotex
Sun Pharma (Ranbaxy)
Nephron Pharma
Beximco Pharma
Hikma (Roxane)
XIANJU PHARMA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhalation and Nasal Spray Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhalation and Nasal Spray Generic Drugs, with price, sales, revenue and global market share of Inhalation and Nasal Spray Generic Drugs from 2019 to 2022.
Chapter 3, the Inhalation and Nasal Spray Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhalation and Nasal Spray Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Inhalation and Nasal Spray Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Inhalation and Nasal Spray Generic Drugs.
Chapter 13, 14, and 15, to describe Inhalation and Nasal Spray Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Inhalation and Nasal Spray Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhalation and Nasal Spray Generic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Corticosteroids
1.2.3 Bronchodilators
1.2.4 Combinations
1.2.5 Decongestant Sprays
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhalation and Nasal Spray Generic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Asthma
1.3.3 COPD
1.3.4 Allergic Rhinitis
1.3.5 Others
1.4 Global Inhalation and Nasal Spray Generic Drugs Market Size & Forecast
1.4.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume (2017-2028)
1.4.3 Global Inhalation and Nasal Spray Generic Drugs Price (2017-2028)
1.5 Global Inhalation and Nasal Spray Generic Drugs Production Capacity Analysis
1.5.1 Global Inhalation and Nasal Spray Generic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Inhalation and Nasal Spray Generic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inhalation and Nasal Spray Generic Drugs Market Drivers
1.6.2 Inhalation and Nasal Spray Generic Drugs Market Restraints
1.6.3 Inhalation and Nasal Spray Generic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Inhalation and Nasal Spray Generic Drugs Product and Services
2.1.4 Teva Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sandoz (Novartis)
2.2.1 Sandoz (Novartis) Details
2.2.2 Sandoz (Novartis) Major Business
2.2.3 Sandoz (Novartis) Inhalation and Nasal Spray Generic Drugs Product and Services
2.2.4 Sandoz (Novartis) Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Inhalation and Nasal Spray Generic Drugs Product and Services
2.3.4 Mylan Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Inhalation and Nasal Spray Generic Drugs Product and Services
2.4.4 Allergan Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Inhalation and Nasal Spray Generic Drugs Product and Services
2.5.4 Cipla Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Akorn
2.6.1 Akorn Details
2.6.2 Akorn Major Business
2.6.3 Akorn Inhalation and Nasal Spray Generic Drugs Product and Services
2.6.4 Akorn Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex Inhalation and Nasal Spray Generic Drugs Product and Services
2.7.4 Apotex Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharma (Ranbaxy)
2.8.1 Sun Pharma (Ranbaxy) Details
2.8.2 Sun Pharma (Ranbaxy) Major Business
2.8.3 Sun Pharma (Ranbaxy) Inhalation and Nasal Spray Generic Drugs Product and Services
2.8.4 Sun Pharma (Ranbaxy) Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Nephron Pharma
2.9.1 Nephron Pharma Details
2.9.2 Nephron Pharma Major Business
2.9.3 Nephron Pharma Inhalation and Nasal Spray Generic Drugs Product and Services
2.9.4 Nephron Pharma Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Beximco Pharma
2.10.1 Beximco Pharma Details
2.10.2 Beximco Pharma Major Business
2.10.3 Beximco Pharma Inhalation and Nasal Spray Generic Drugs Product and Services
2.10.4 Beximco Pharma Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hikma (Roxane)
2.11.1 Hikma (Roxane) Details
2.11.2 Hikma (Roxane) Major Business
2.11.3 Hikma (Roxane) Inhalation and Nasal Spray Generic Drugs Product and Services
2.11.4 Hikma (Roxane) Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 XIANJU PHARMA
2.12.1 XIANJU PHARMA Details
2.12.2 XIANJU PHARMA Major Business
2.12.3 XIANJU PHARMA Inhalation and Nasal Spray Generic Drugs Product and Services
2.12.4 XIANJU PHARMA Inhalation and Nasal Spray Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Inhalation and Nasal Spray Generic Drugs Breakdown Data by Manufacturer
3.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Inhalation and Nasal Spray Generic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Inhalation and Nasal Spray Generic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Inhalation and Nasal Spray Generic Drugs Manufacturer Market Share in 2021
3.5 Global Inhalation and Nasal Spray Generic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Inhalation and Nasal Spray Generic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inhalation and Nasal Spray Generic Drugs Market Size by Region
4.1.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2028)
4.2 North America Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.3 Europe Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.5 South America Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Inhalation and Nasal Spray Generic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Type (2017-2028)
5.3 Global Inhalation and Nasal Spray Generic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Inhalation and Nasal Spray Generic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Inhalation and Nasal Spray Generic Drugs Revenue by Application (2017-2028)
6.3 Global Inhalation and Nasal Spray Generic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
7.2 North America Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
7.3 North America Inhalation and Nasal Spray Generic Drugs Market Size by Country
7.3.1 North America Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
8.2 Europe Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
8.3 Europe Inhalation and Nasal Spray Generic Drugs Market Size by Country
8.3.1 Europe Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Market Size by Region
9.3.1 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Inhalation and Nasal Spray Generic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
10.2 South America Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
10.3 South America Inhalation and Nasal Spray Generic Drugs Market Size by Country
10.3.1 South America Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Market Size by Country
11.3.1 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Inhalation and Nasal Spray Generic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Inhalation and Nasal Spray Generic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Inhalation and Nasal Spray Generic Drugs
12.3 Inhalation and Nasal Spray Generic Drugs Production Process
12.4 Inhalation and Nasal Spray Generic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Inhalation and Nasal Spray Generic Drugs Typical Distributors
13.3 Inhalation and Nasal Spray Generic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---